Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,898.31 -2,066.12 (-3.28%) CMC Crypto 200
1,260.85 -97.16 (-7.16%)
ACADIA Pharmaceuticals Inc. (ACAD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.21 |
| Open | 15.30 |
| Bid | 15.21 x 200 |
| Ask | 15.26 x 500 |
| Day's range | 15.11 - 15.53 |
| 52-week range | 15.11 - 33.99 |
| Volume | |
| Avg. volume | 1,901,554 |
| Market cap | 2.52B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
ACADIA Pharmaceuticals Q1 2024 Earnings: Solid Growth with New Product Launches
ACADIA's Revenue Surges with Strong Sales from NUPLAZID and DAYBUE
- Simply Wall St.
ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
ACADIA Pharmaceuticals ( NASDAQ:ACAD ) First Quarter 2024 Results Key Financial Results Revenue: US$205.8m (up 74% from...
- Insider Monkey
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 […]
© 2024 Yahoo. All rights reserved.